NCT05691790

Brief Summary

Objectives: To empower older people's decision making for taking the recommended vaccines including seasonal influenza vaccines, pneumococcal vaccines, and COVID-19 vaccine (if it is recommended annually). Hypotheses to be tested: The interventions designed using Mental Models Approach and Patient Activation Approach will promote older people's confidence in knowledge and skills regarding vaccination decisions, perceived self-efficacy in self-management of health, positive emotional engagement with vaccination decisions and a positive future time perspective which will subsequently promote their uptake of the recommended vaccines. Design and subjects: This will be a two-arm randomized control trial. Subjects will be community-dwelling older people aged 70 years or above. Instruments: A questionnaire will be used to collect baseline data before the interventions and follow-up data 1 months and 4 months, respectively, after the end of interventions. Interventions: Interventions included one booklet to communicate information about preventive care by bridging expert knowledge and older people's existing mental models, and six patient activation sections conducted over telephone. One patient activation section will be delivered per week by trained medical students. Main outcome measures: Main outcomes will be participants' uptake of the three recommended vaccines assessed at 1 month and 4 months after the end of interventions. Data analysis and expected results: Generalized estimating equation logistic regression will be used to assess the intervention effects. The investigators expect that the interventions can promote at least 20% increase in uptake of any one of the three recommended vaccines in the intervention group compared with the control group.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
270

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 28, 2022

Completed
23 days until next milestone

First Posted

Study publicly available on registry

January 20, 2023

Completed
1.7 years until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

March 30, 2025

Status Verified

March 1, 2025

Enrollment Period

8 months

First QC Date

December 28, 2022

Last Update Submit

March 25, 2025

Conditions

Keywords

Older peoplePreventive careVaccine decision-making

Outcome Measures

Primary Outcomes (1)

  • Change of Uptake Rate of the Three Recommended Vaccines from Baseline to within 1 Month and 4 Months after Interventions

    Participants' uptake rate of the three recommended vaccines (influenza vaccines, pneumococcal vaccines, and COVID-19 vaccines).

    Assessed at baseline, within 1 month and 4 months after the end of interventions.

Secondary Outcomes (5)

  • Changes in Patient Activation Measure from baseline to within 1 month after intervention ends

    At baseline and within one month after the end of the intervention (in the 1st follow-up assessment)

  • Changes in Emotional engagement with vaccination decisions measurement from baseline to within 1 month after intervention ends

    At baseline and within one month after the end of the intervention (in the 1st follow-up assessment)

  • Changes in Future time perspective measurement from baseline to within 1 month after intervention ends

    At baseline and within one month after the end of the intervention (in the 1st follow-up assessment)

  • Changes in lifestyle behaviours from baseline to within 1 month and 4 months after intervention ends

    At baseline and within one month (in the 1st follow-up assessment) and four months (2nd outcome assessment)after the end of the intervention

  • Changes in other preventive care utilization from baseline to within 1 month and 4 months after intervention ends

    At baseline and within one month (in the 1st follow-up assessment) four months (2nd outcome assessment) after the end of the intervention

Study Arms (2)

Control Group

ACTIVE COMPARATOR

Participants who are allocated to the control group will receive a pamphlet about recommendation for influenza vaccines, pneumococcal vaccines, and COVID-19 vaccines (if appropriate) for older people using information from Hong Kong Department of Health. This group will receive six control telephone care visits over six weeks. We will purposively balance the characteristics of the student helpers who do the control telephone visits and the patient activation interviews. Each control telephone care visit will be around 5-10 min during which the student helper will give general guidelines about dietary health and exercise for older people. The control messages are mainly educational and designed using information derived from the websites of Hong Kong Department of Health. In the last telephone care visit, the interviewer will give a summary for how to live a healthy lifestyle and a reminder of taking the recommended vaccinations for older people shown in the pamphlet.

Behavioral: Control Group

Intervention Group

EXPERIMENTAL

Intervention development and delivery The interventions will involve deliver a booklet designed based on MMA and six telephone interviews for patient activation. Design of booklet for older people's preventive care: The booklet will be framed as one series of "Positive aging via preventive care"-vaccination. According to MMA, the booklet will be aimed to translate expert knowledge into information that can fit to older people's mental models (e.g., misperceptions and knowledge deficits revealed in our previous qualitative studies) regarding vaccinations to facilitate cognitive process of the information. Patient activation sections: We will design six telephone-based patient activation sections with accommodation for older people's mental models and decision-making preference. The motivation interviewing (MI) techniques will be incorporated into the design of patient activation sections.

Behavioral: MMA and patient activation intervention scheme

Interventions

Design of booklet for older people's preventive care: We propose that the booklet will include 8 main topics based on what experts and current academic literature believe are important for encouraging older people's preventive care utilization. To add the social norms-related cues for the later three topics of the booklet, one qualitative study on older adults who are active in preventive care is needed. Therefore, we will interview \~20 older adults aged 70 years or above who are active in taking preventive care. We will conduct one-to-one in-depth interview to explore how participants overcome difficulties during decision making for vaccination and their positive feelings after making achievements. We will also explore and identify older adults who have a positive future perspective. Patient activation sections: . Four undergraduate medical students will be trained as the coaches to deliver the patient activation sections over six weeks. Each section will be around 20 min.

Intervention Group
Control GroupBEHAVIORAL

Participants in the control group will receive a pamphlet about recommendation for influenza, pneumococcal, and COVID-19 vaccines (if appropriate) for older people using information from Hong Kong Department of Health. As a control for the patient activation interviews, the control group will also be informed that they will join our "telephone-based elderly care project" by the end of the baseline assessment but instead of receiving the patient activation interviews, this group will receive six control telephone care visits over six weeks. Each control telephone care visit will be around 5-10 min during which the student helper will give general guidelines about dietary health and exercise for older people. The control messages are mainly educational and designed using information derived from the websites of Hong Kong Department of Health.

Control Group

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Community-dwelling older persons aged 70 years who did not persistently receive seasonal influenza vaccine over the past three years (2020-2022) and/or have never received the pneumococcal vaccine (one dose of the 23-valent pneumococcal polysaccharide vaccine (23vPPV) or the 13-valent pneumococcal conjugate vaccine (PCV13)).
  • Being able to communicate with Cantonese, or Mandarin (the two main spoken language in Hong Kong) and being able to read Chinese.

You may not qualify if:

  • having psychiatric disorders, dementia, or other cognitive difficulties which impede communication or understanding of the intervention and having functional disabilities which impede access to health care services.
  • subjects who had medical contraindications for immunization.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Public Health, The University of Hong Kong

Hong Kong, China, HKG, Hong Kong

RECRUITING

Related Publications (25)

  • United Nations Development Programme. Human development report 2013: the rise of the South: human progress in a diverse world. 2013 [Available from: https://hdr.undp.org/en/global-reports.

    BACKGROUND
  • Wong K, Yeung M. Population aging trend of Hong Kong: Office of the Government Economist, The Government of the Hong Kong Special Administrative Region; 2019 [Available from: https://www.hkeconomy.gov.hk/en/pdf/el/el-2019-02.pdf.

    BACKGROUND
  • Hong Kong Census and Statistics Department. Thematic Household Survey Report No. 40: socio-demographic profile, health status and self-care capability of older persons. 2009 [Available from: https://www.censtatd.gov.hk/en/data/stat_report/product/C0000071/att/B11302402009XXXXB0100.pdf.

    BACKGROUND
  • Mytton OT, Jackson C, Steinacher A, Goodman A, Langenberg C, Griffin S, Wareham N, Woodcock J. The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: A microsimulation study. PLoS Med. 2018 Mar 6;15(3):e1002517. doi: 10.1371/journal.pmed.1002517. eCollection 2018 Mar.

    PMID: 29509767BACKGROUND
  • Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet. 2005 Oct 1;366(9492):1165-74. doi: 10.1016/S0140-6736(05)67339-4. Epub 2005 Sep 22.

    PMID: 16198765BACKGROUND
  • Yin M, Huang L, Zhang Y, Yu N, Xu X, Liang Y, Ni J. Effectiveness and safety of dual influenza and pneumococcal vaccination versus separate administration or no vaccination in older adults: a meta-analysis. Expert Rev Vaccines. 2018 Jul;17(7):653-663. doi: 10.1080/14760584.2018.1495077. Epub 2018 Jul 16.

    PMID: 29961353BACKGROUND
  • Hong Kong Department of Health. Report of Population Health Survey 2014/2015 2017 [Available from: https://www.chp.gov.hk/files/pdf/dh_phs_2014_15_full_report_eng.pdf.

    BACKGROUND
  • Hong Kong Center for Health Protection. Statistics on vaccination programmes in the past 3 years 2022 [Available from: https://www.chp.gov.hk/en/features/102226.html.

    BACKGROUND
  • Hong Kong Center for Health Protection. COVID-19 vaccination programme: Hong Kong Vaccination Dashboard: The Government of the Hong Kong Special Administrative Region; 2022 [Available from: https://www.covidvaccine.gov.hk/en/dashboard.

    BACKGROUND
  • Badham SP, Hamilton CA. Influences of Complexity on Decision Making in Young and Older Adults. Eur J Psychol. 2020 May 29;16(2):280-299. doi: 10.5964/ejop.v16i2.1958. eCollection 2020 May.

    PMID: 33680183BACKGROUND
  • Peters E, de Bruin WB. Aging and decision skills. In: Dhami MK, Schlottmann A, Waldmann MR, editors. Judgment and decision making as a skill: learning, development and evolution: Cambridge University Press; 2012. p. 113-39.

    BACKGROUND
  • Finucane ML, Gullion CM. Developing a tool for measuring the decision-making competence of older adults. Psychol Aging. 2010 Jun;25(2):271-88. doi: 10.1037/a0019106.

    PMID: 20545413BACKGROUND
  • Carstensen LL. The influence of a sense of time on human development. Science. 2006 Jun 30;312(5782):1913-5. doi: 10.1126/science.1127488.

    PMID: 16809530BACKGROUND
  • Reinhardt A, Rossmann C. Age-related framing effects: Why vaccination against COVID-19 should be promoted differently in younger and older adults. J Exp Psychol Appl. 2021 Dec;27(4):669-678. doi: 10.1037/xap0000378. Epub 2021 Jul 22.

    PMID: 34292048BACKGROUND
  • Liu X, Ji L, Peng H. The impacts of task relevance and cognitive load on adults' decision information search. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2021 Jan;28(1):78-96. doi: 10.1080/13825585.2020.1712320. Epub 2020 Jan 11.

    PMID: 31928164BACKGROUND
  • Bruine de Bruin W, Parker AM, Fischhoff B. Individual differences in adult decision-making competence. J Pers Soc Psychol. 2007 May;92(5):938-956. doi: 10.1037/0022-3514.92.5.938.

    PMID: 17484614BACKGROUND
  • Liao Q, Lau W, McGhee S, Yap M, Sum R, Liang J, Lian J. Barriers to preventive care utilization among Hong Kong community-dwelling older people and their views on using financial incentives to improve preventive care utilization. Health Expect. 2021 Aug;24(4):1242-1253. doi: 10.1111/hex.13256. Epub 2021 May 5.

    PMID: 33949749BACKGROUND
  • Ronnlund M, Del Missier F, Mantyla T, Carelli MG. The Fatalistic Decision Maker: Time Perspective, Working Memory, and Older Adults' Decision-Making Competence. Front Psychol. 2019 Sep 12;10:2038. doi: 10.3389/fpsyg.2019.02038. eCollection 2019.

    PMID: 31572258BACKGROUND
  • Strough J, de Bruin WB, Peters E. New perspectives for motivating better decisions in older adults. Front Psychol. 2015 Jun 22;6:783. doi: 10.3389/fpsyg.2015.00783. eCollection 2015.

    PMID: 26157398BACKGROUND
  • Bruine de Bruin W, Bostrom A. Assessing what to address in science communication. Proc Natl Acad Sci U S A. 2013 Aug 20;110 Suppl 3(Suppl 3):14062-8. doi: 10.1073/pnas.1212729110. Epub 2013 Aug 13.

    PMID: 23942122BACKGROUND
  • Hibbard JH, Mahoney E. Toward a theory of patient and consumer activation. Patient Educ Couns. 2010 Mar;78(3):377-81. doi: 10.1016/j.pec.2009.12.015. Epub 2010 Feb 25.

    PMID: 20188505BACKGROUND
  • Hibbard JH, Mahoney ER, Stock R, Tusler M. Do increases in patient activation result in improved self-management behaviors? Health Serv Res. 2007 Aug;42(4):1443-63. doi: 10.1111/j.1475-6773.2006.00669.x.

    PMID: 17610432BACKGROUND
  • Bandura A. Self-Efficacy. The Corsini Encyclopedia of Psychology. p. 1-3.

    BACKGROUND
  • Sinclair AH, Stanley ML, Hakimi S, Cabeza R, Adcock RA, Samanez-Larkin GR. Imagining a Personalized Scenario Selectively Increases Perceived Risk of Viral Transmission for Older Adults. Nat Aging. 2021 Aug;1(8):677-683. doi: 10.1038/s43587-021-00095-7. Epub 2021 Aug 5.

    PMID: 35990532BACKGROUND
  • Dobler A, Herbeck Belnap B, Pollmann H, Farin E, Raspe H, Mittag O. Telephone-delivered lifestyle support with action planning and motivational interviewing techniques to improve rehabilitation outcomes. Rehabil Psychol. 2018 May;63(2):170-181. doi: 10.1037/rep0000224.

    PMID: 29878825BACKGROUND

MeSH Terms

Interventions

Methylmalonic AcidControl Groups

Intervention Hierarchy (Ancestors)

MalonatesDicarboxylic AcidsAcids, AcyclicCarboxylic AcidsOrganic ChemicalsEpidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Central Study Contacts

Qiuyan Liao

CONTACT

Yuyi Chen

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 28, 2022

First Posted

January 20, 2023

Study Start

October 1, 2024

Primary Completion

May 31, 2025

Study Completion

May 31, 2025

Last Updated

March 30, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

Only the Principal Investigator (PI) and the designated research assistant of the research project will have access to the personal data during and after the study. After the study findings are published, an anonymous dataset will be created and managed by the PI from this project and made publicly accessible upon reasonable request by other research PIs for the purpose of research use only. PI will be responsible for safekeeping of the personal data during and after the study.

Shared Documents
SAP
Time Frame
After the study findings are published, an anonymous dataset will be created and managed by the PI from this project and made publicly accessible upon reasonable request by other research PIs for the purpose of research use only. The data will be available for 10 years after publishing.
Access Criteria
For research use only.

Locations